Technology
iRobot Reports Third-Quarter 2024 Financial Results
Published
2 years agoon
By
Continues to Make Progress on “iRobot Elevate” Strategy
Revises Full-year 2024 Outlook
BEDFORD, Mass., Nov. 6, 2024 /PRNewswire/ — iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the third quarter ended September 28, 2024.
“We continue to make progress on our turnaround strategy,” said Gary Cohen, iRobot’s CEO. “In the third quarter, we expanded our non-GAAP gross margin by 590 basis points year over year and improved our use of operating cash. However, our overall results did not meet the expectations we set in August, as persistent market segment and competitive headwinds impacted our sell-through performance. Although we now expect it will take more time to stabilize our revenue trend, we are on track to exceed our operating expense targets for the year, while at the same time continuing to invest in areas that are expected to drive growth.
“Our ongoing restructuring has fundamentally changed the way we innovate, develop and build our robots, which is central to improving our performance and generating long-term shareholder value. With the benefit of lower operating costs, we expect to enhance margins and improve profitability in 2025.
“As we move forward in this new chapter in iRobot’s history, one thing is abundantly clear: we have a powerful brand that will serve as the foundation for the turnaround of this Company. That brand power is at the heart of our turnaround strategy, iRobot Elevate. In executing that strategy, we are focused on providing our iconic brand with an improved platform to drive long-term profitable growth.”
Third-Quarter 2024 Financial Results (in millions, except per share amounts and percentages)
Q3 2024
Q3 2023
Revenue
$193.4
$186.2
GAAP Gross Margin
32.2 %
25.8 %
Non-GAAP Gross Margin
32.4 %
26.5 %
GAAP Operating Expenses
$55.1
$107.5
Non-GAAP Operating Expenses
$47.7
$90.1
GAAP Operating Income (Loss)
$7.3
($59.5)
Non-GAAP Operating Income (Loss)
$15.1
($40.6)
GAAP Net Loss Per Share
($0.21)
($2.86)
Non-GAAP Net Income (Loss) Per Share*
$0.03
($2.82)
*Beginning in the fourth quarter of fiscal 2023, the Company updated its calculation of non-GAAP financial measures to no longer exclude “IP litigation expense, net.” The metrics are presented in accordance with this updated methodology. As a result, the third quarter ended September 30, 2023 differs from those previously presented by the amount of IP litigation expense, net recorded in such period.
Additional Financial Highlights
The Company increased non-GAAP gross margin in the third quarter by 590 basis points year over year as a result of its restructuring and iRobot Elevate initiatives.As of September 28, 2024, the Company’s cash and cash equivalents totaled $99.4 million, compared with $108.5 million as of the end of the second quarter of 2024. The Company also had an additional $41.1 million restricted cash set aside for future repayment of its term loan, subject to limited rights for inventory purchases, of which $40.0 million was drawn down at the close of the third quarter and received in the fourth quarter.As of September 28, 2024, the Company’s inventory totaled $149.2 million, compared with $244.5 million as of the end of the third quarter of 2023.During the third quarter, the Company sold 0.2 million shares under its at-the-market (ATM) offering program for total net proceeds of $1.4 million. At quarter end, the Company had $79.6 million remaining under its $100 million ATM offering program.As of September 28, 2024, iRobot had reduced its total headcount by 41% since year-end 2023.In the third quarter of 2024, revenue increased 23% in the U.S., declined 20% in Japan, and declined 11% in EMEA over the prior-year period. Excluding the unfavorable foreign currency impact, Japan revenue decreased 15% over the prior-year period.Revenue from mid-tier robots (with an MSRP between $300 and $499) and premium robots (with an MSRP of $500 or more) represented 79% of total robot sales in the third quarter of 2024, compared with 80% in the same period last year.
Marketing Highlights
iRobot introduced the 2-in-1 Roomba Combo 2 Essential robot globally and Roomba Vac 2 Essential robot in North America. These robots are the first in the Company’s affordable Essential series that automatically empty their dustbins into the AutoEmpty dock after cleaning. The robots also provide twice the cleaning power of the original Essential series, include an enhanced bumper design to more seamlessly navigate floor space, and have the ability to recharge and resume during cleaning missions.In August, iRobot launched the Roomba Combo 10 Max in Japan, earning positive coverage in media outlets including Nikkei, NHK and Gizmodo.iRobot Roomba Combo Essential received the PCMag Editor’s Choice designation.iRobot products received favorable media coverage across the globe, including from CBS News, Engadget, The Verge, Tom’s Guide, ZDNet, The Ambient, and Europa Press.Roomba was a featured product in Amazon’s Prime Big Deal Days event in October. iRobot’s products received Prime Big Deal Day related media coverage in outlets including Good Morning America, NBC Select, The Sun, Frandroid and El Confidencial.
Fourth-Quarter and Full-Year 2024 Outlook
iRobot is providing GAAP and non-GAAP financial expectations for the fourth quarter ending December 28, 2024 and updating the full-year 2024 outlook it provided on August 7, 2024. A detailed reconciliation between the Company’s GAAP and non-GAAP expectations is included in the financial tables that appear at the end of this press release.
Fourth Quarter 2024:
Metric
GAAP
Adjustments
Non-GAAP
Revenue
$175 – $200 million
—
$175 – $200 million
Gross Margin
24% – 27%
~0%
24% – 27%
Operating Loss
($43) – ($34) million
~$12 million
($31) – ($22) million
Net Loss Per Share
($1.88) – ($1.58)
~$0.38
($1.50) – ($1.20)
Fiscal Year 2024:
Metric
GAAP
Adjustments
Non-GAAP
Revenue
$685 – $710 million
—
$685 – $710 million
Gross Margin
25% – 26%
~0%
25% – 26%
Operating Loss
($84) – ($75) million
~($20) million
($104) – ($95) million
Net Loss Per Share
($4.27) – ($3.96)
~($0.64)
($4.91) – ($4.60)
Third-Quarter 2024 Results Conference Call
On November 6, the Company will host a live conference call and webcast to review its financial results and discuss its outlook. The conference call details are as follows:
Date: Wednesday, November 6, 2024
Time: 8:30 a.m. ET
Call-In Number: 800-274-8461 (Alternate: 203-518-9814)
Conference ID: IRBTQ324
A live webcast of the conference call will be accessible on the event section of the Company’s website at https://investor.irobot.com/financial-information/quarterly-results. An archived version of the broadcast will be available on the same website shortly after the conclusion of the live event.
About iRobot Corp.
iRobot is a global consumer robot company that designs and builds thoughtful robots and intelligent home innovations that make life better. iRobot introduced the first Roomba robot vacuum in 2002. Today, iRobot is a global enterprise that has sold more than 50 million robots worldwide. iRobot’s product portfolio features technologies and advanced concepts in cleaning, mapping and navigation. Working from this portfolio, iRobot engineers are building robots and smart home devices to help consumers make their homes easier to maintain and healthier places to live. For more information about iRobot, please visit www.irobot.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which relate to, among other things: the Company’s expectations regarding future financial performance, including with respect to fourth quarter and fiscal year 2024 revenue, gross margin, operating (loss) income and net (loss) income per share, as well as fiscal year 2025 operating costs, margins and profitability; executing on the Company’s iRobot Elevate strategy; stabilization of revenue trends; and the Company’s business plans and strategies and the anticipated impact thereof. These forward-looking statements are based on the Company’s current expectations, estimates and projections about its business and industry, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “see,” “will,” “may,” “would,” “might,” “potentially,” “estimate,” “continue,” “expect,” “target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the Company’s ability to obtain capital when desired on favorable terms, if at all; (ii) the Company’s ability to realize the benefits of its operational restructuring; (iii) the impact of the COVID-19 pandemic and various global conflicts on the Company’s business and general economic conditions; (iv) the Company’s ability to implement its business strategy; (v) the risk that disruptions from the operational restructuring will harm the Company’s business, including current plans and operations; (vi) the ability of the Company to retain and hire key personnel, including successfully navigating its leadership transition; (vii) legislative, regulatory and economic developments affecting the Company’s business; (viii) general economic and market developments and conditions; (ix) the evolving legal, regulatory and tax regimes under which the Company operates; (x) potential business uncertainty, including changes to existing business relationships that could affect the Company’s financial performance; (xi) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities; (xii) current supply chain challenges including the Red Sea conflict; (xiii) the financial strength of our customers and retailers; (xiv) the impact of tariffs on goods imported into the United States; and (xv) competition, as well as the Company’s response to any of the aforementioned factors. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption “Risk Factors” in the Company’s most recent annual and quarterly reports filed with the SEC and any subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed from time to time and available at www.sec.gov. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability and similar risks, any of which could have a material adverse effect on the Company’s financial condition, results of operations, or liquidity. The forward-looking statements included herein are made only as of the date hereof. The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
iRobot Corporation
Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
For the three months ended
For the nine months ended
September 28, 2024
September 30, 2023
September 28, 2024
September 30, 2023
Revenue
$ 193,435
$ 186,176
$ 509,811
$ 583,036
Cost of revenue:
Cost of product revenue
131,058
137,888
383,865
443,932
Amortization of acquired intangible assets
–
292
–
864
Total cost of revenue
131,058
138,180
383,865
444,796
Gross profit
62,377
47,996
125,946
138,240
Operating expenses:
Research and development
19,630
37,336
76,739
116,576
Selling and marketing
29,270
41,558
98,966
139,630
General and administrative
3,232
28,270
(33,552)
85,116
Restructuring and other
1,922
152
24,298
8,236
Amortization of acquired intangible assets
1,066
174
1,405
529
Total operating expenses
55,120
107,490
167,856
350,087
Operating income (loss)
7,257
(59,494)
(41,910)
(211,847)
Other expense, net
(12,548)
(19,113)
(24,583)
(24,217)
Loss before income taxes
(5,291)
(78,607)
(66,493)
(236,064)
Income tax expense
1,080
598
1,917
5,053
Net loss
$ (6,371)
$ (79,205)
$ (68,410)
$ (241,117)
Net loss per share:
Basic
$ (0.21)
$ (2.86)
$ (2.34)
$ (8.73)
Diluted
$ (0.21)
$ (2.86)
$ (2.34)
$ (8.73)
Number of shares used in per share calculations:
Basic
30,348
27,738
29,276
27,608
Diluted
30,348
27,738
29,276
27,608
Stock-based compensation included in above figures:
Cost of revenue
$ 387
$ 838
$ 1,486
$ 2,226
Research and development
1,296
3,355
4,994
8,737
Selling and marketing
903
1,384
3,403
4,221
General and administrative
2,894
3,798
8,054
10,696
Total
$ 5,480
$ 9,375
$ 17,937
$ 25,880
iRobot Corporation
Condensed Consolidated Balance Sheets
(unaudited, in thousands)
September 28, 2024
December 30, 2023
Assets
Cash and cash equivalents
$ 99,447
$ 185,121
Restricted cash
41,082
–
Accounts receivable, net
101,326
79,387
Inventory
149,156
152,469
Other current assets
32,774
48,513
Total current assets
423,785
465,490
Property and equipment, net
25,405
40,395
Operating lease right-of-use assets
15,137
19,642
Deferred tax assets
9,093
8,512
Goodwill
175,928
175,105
Intangible assets, net
3,635
5,044
Other assets
16,932
19,510
Total assets
$ 669,915
$ 733,698
Liabilities and stockholders’ equity
Accounts payable
$ 195,133
$ 178,318
Accrued expenses
88,384
97,999
Deferred revenue and customer advances
9,121
10,830
Total current liabilities
292,638
287,147
Term loan
186,713
201,501
Operating lease liabilities
22,892
27,609
Other long-term liabilities
17,510
20,954
Total long-term liabilities
227,115
250,064
Total liabilities
519,753
537,211
Stockholders’ equity
150,162
196,487
Total liabilities and stockholders’ equity
$ 669,915
$ 733,698
iRobot Corporation
Consolidated Statements of Cash Flows
(unaudited, in thousands)
For the nine months ended
September 28, 2024
September 30, 2023
Cash flows from operating activities:
Net loss
$ (68,410)
$ (241,117)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
16,912
21,367
Loss on equity investment
375
3,910
Stock-based compensation
17,937
25,880
Provision for inventory excess and obsolescence
11,800
1,740
Change in fair value of term loan
13,515
5,292
Debt issuance costs expensed under fair value option
529
11,837
Deferred income taxes, net
(651)
4,115
Other
(6,318)
(8,618)
Changes in operating assets and liabilities — (use) source
Accounts receivable
(22,073)
(7,943)
Inventory
(10,539)
32,935
Other assets
15,598
12,544
Accounts payable
16,674
28,904
Accrued expenses and other liabilities
(15,825)
(4,483)
Net cash used in operating activities
(30,476)
(113,637)
Cash flows from investing activities:
Additions of property and equipment
(118)
(3,132)
Purchase of investments
(56)
(213)
Net cash used in investing activities
(174)
(3,345)
Cash flows from financing activities:
Proceeds from employee stock plans
–
9
Income tax withholding payment associated with restricted stock vesting
(491)
(1,924)
Proceeds from issuance of common stock, net of issuance costs
19,359
–
Repayment of term loan
(34,947)
–
Proceeds from term loan
–
200,000
Payment of debt issuance costs
(529)
(11,837)
Net cash (used in) provided by financing activities
(16,608)
186,248
Effect of exchange rate changes on cash, cash equivalents and restricted cash
1,251
4,193
Net (decrease) increase in cash, cash equivalents and restricted cash
(46,007)
73,459
Cash, cash equivalents and restricted cash, at beginning of period
187,887
117,949
Cash, cash equivalents and restricted cash, at end of period
$ 141,880
$ 191,408
Cash, cash equivalents and restricted cash, at end of period:
Cash and cash equivalents
$ 99,447
$ 189,649
Restricted cash
41,082
–
Restricted cash, non-current (included in other assets)
1,351
1,759
Cash, cash equivalents and restricted cash, at end of period
$ 141,880
$ 191,408
iRobot Corporation
Supplemental Information
(unaudited)
For the three months ended
For the nine months ended
September 28, 2024
September 30, 2023
September 28, 2024
September 30, 2023
Revenue by Geography: *
Domestic
$ 105,137
$ 85,781
$ 258,398
$ 288,725
International
88,298
100,395
251,413
294,311
Total
$ 193,435
$ 186,176
$ 509,811
$ 583,036
Robot Units Shipped *
Solo and other
287
446
854
1,492
2-in-1
445
181
908
403
Total
732
627
1,762
1,895
Revenue by Product Category **
Solo and other
$ 83
$ 126
$ 268
$ 449
2-in-1
110
60
242
134
Total
$ 193
$ 186
$ 510
$ 583
Average gross selling prices for robot units
$ 313
$ 331
$ 329
$ 354
Headcount
661
1,126
* in thousands
** in millions
Certain numbers may not total due to rounding
iRobot Corporation
Explanation of Non-GAAP Measures
In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures.
Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated.
Amortization of acquired intangible assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations as well as any non-cash impairment charges associated with intangible assets in connection with our past acquisitions. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of transaction fees, professional fees, and transition and integration costs directly associated with mergers, acquisitions and divestitures, including with respect to the iRobot-Amazon Merger. It also includes business combination adjustments including adjustments after the measurement period has ended. During the first quarter of fiscal 2024, the adjustment included the one-time net termination fee received as a result of the termination of the iRobot-Amazon Merger. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies.
Restructuring and Other: Restructuring charges are related to one-time actions associated with realigning resources, enhancing operational productivity and efficiency, or improving our cost structure in support of our strategy. Such actions are not reflective of ongoing operations and include costs primarily associated with severance and related costs, charges related to paused work unrelated to our core business, costs associated with the Chief Executive Officer transition and other non-recurring costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude these items from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business.
Gain/Loss on Strategic Investments: Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance.
Debt issuance costs: Debt issuance costs include various incremental fees and commissions paid to third parties in connection with the issuance of debt. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Income tax adjustments: Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We regularly assess the need to record valuation allowances based on the non-GAAP profitability and other factors. We also exclude certain tax items, including the impact from stock-based compensation windfalls/shortfalls, which are not reflective of income tax expense incurred as a result of current period earnings. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors’ consistent earnings comparison between periods.
iRobot Corporation
Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals
(in thousands, except per share amounts)
(unaudited)
For the three months ended
For the nine months ended
September 28, 2024
September 30, 2023
September 28, 2024
September 30, 2023
GAAP Revenue
$ 193,435
$ 186,176
$ 509,811
$ 583,036
GAAP Gross Profit
$ 62,377
$ 47,996
$ 125,946
$ 138,240
Amortization of acquired intangible assets
–
292
–
864
Stock-based compensation
387
838
1,486
2,226
Net merger, acquisition and divestiture expense
–
288
–
898
Non-GAAP Gross Profit
$ 62,764
$ 49,414
$ 127,432
$ 142,228
GAAP Gross Margin
32.2 %
25.8 %
24.7 %
23.7 %
Non-GAAP Gross Margin
32.4 %
26.5 %
25.0 %
24.4 %
GAAP Operating Expenses
$ 55,120
$ 107,490
$ 167,856
$ 350,087
Amortization of acquired intangible assets
(1,066)
(174)
(1,405)
(529)
Stock-based compensation
(5,093)
(8,537)
(16,451)
(23,654)
Net merger, acquisition and divestiture income (expense)
656
(8,564)
74,813
(21,991)
Restructuring and other
(1,922)
(152)
(24,298)
(8,236)
Non-GAAP Operating Expenses*
$ 47,695
$ 90,063
$ 200,515
$ 295,677
GAAP Operating Expenses as a % of GAAP Revenue
28.5 %
57.7 %
32.9 %
60.0 %
Non-GAAP Operating Expenses as a % of Non-GAAP Revenue*
24.7 %
48.4 %
39.3 %
50.7 %
GAAP Operating Income (Loss)
$ 7,257
$ (59,494)
$ (41,910)
$ (211,847)
Amortization of acquired intangible assets
1,066
466
1,405
1,393
Stock-based compensation
5,480
9,375
17,937
25,880
Net merger, acquisition and divestiture (income) expense
(656)
8,852
(74,813)
22,889
Restructuring and other
1,922
152
24,298
8,236
Non-GAAP Operating Income (Loss)*
$ 15,069
$ (40,649)
$ (73,083)
$ (153,449)
GAAP Operating Margin
3.8 %
(32.0) %
(8.2) %
(36.3) %
Non-GAAP Operating Margin*
7.8 %
(21.8) %
(14.3) %
(26.3) %
iRobot Corporation
Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals continued
(in thousands, except per share amounts)
(unaudited)
For the three months ended
For the nine months ended
September 28, 2024
September 30, 2023
September 28, 2024
September 30, 2023
GAAP Income Tax Expense
$ 1,080
$ 598
$ 1,917
$ 5,053
Tax effect of non-GAAP adjustments
650
32,045
1,667
565
Other tax adjustments
(203)
(1,638)
(811)
(4,150)
Non-GAAP Income Tax Expense
$ 1,527
$ 31,005
$ 2,773
$ 1,468
GAAP Net Loss
$ (6,371)
$ (79,205)
$ (68,410)
$ (241,117)
Amortization of acquired intangible assets
1,066
466
1,405
1,393
Stock-based compensation
5,480
9,375
17,937
25,880
Net merger, acquisition and divestiture (income) expense
(656)
8,852
(74,813)
22,889
Restructuring and other
1,922
152
24,298
8,236
Loss on strategic investments
–
758
375
3,910
Debt issuance costs
52
11,837
529
11,837
Income tax effect
(447)
(30,407)
(856)
3,585
Non-GAAP Net Income (Loss)*
$ 1,046
$ (78,172)
$ (99,535)
$ (163,387)
GAAP Net Loss Per Diluted Share
$ (0.21)
$ (2.86)
$ (2.34)
$ (8.73)
Amortization of acquired intangible assets
0.03
0.02
0.05
0.05
Stock-based compensation
0.18
0.34
0.61
0.93
Net merger, acquisition and divestiture (income) expense
(0.02)
0.32
(2.55)
0.83
Restructuring and other
0.06
–
0.83
0.30
Loss on strategic investments
–
0.03
0.01
0.14
Debt issuance costs
–
0.43
0.02
0.43
Income tax effect
(0.01)
(1.10)
(0.03)
0.13
Non-GAAP Net Income (Loss) Per Diluted Share*
$ 0.03
$ (2.82)
$ (3.40)
$ (5.92)
Number of shares used in diluted per share calculation
30,551
27,738
29,276
27,608
Supplemental Information
Days sales outstanding
48
36
GAAP Days in inventory
104
161
Non-GAAP Days in inventory(1)
104
163
* Beginning in the fourth quarter of fiscal 2023, we updated our calculation of non-GAAP financial measures to no longer exclude “IP litigation expense, net.” The metrics for each period are presented in accordance with this updated methodology; as a result, the third quarter and the nine months ended September 30, 2023 differ from those previously presented by the amount of IP litigation expense, net recorded in such period.
(1) Non-GAAP Days in inventory is calculated as inventory divided by (Revenue minus Non-GAAP Gross Profit), multiplied by 91 days.
iRobot Corporation
Supplemental Reconciliation of Fourth Quarter and Full Year 2024 GAAP to Non-GAAP Guidance
(unaudited)
Q4-24
FY-24
GAAP Gross Profit
$42 – $54 million
$168 – $179 million
Stock-based compensation
~$0 million
~$2 million
Total adjustments
~$0 million
~$2 million
Non-GAAP Gross Profit
$42 – $54 million
$170 – $181 million
Q4-24
FY-24
GAAP Gross Margin
24% – 27%
25% – 26%
Stock-based compensation
~0%
~0%
Total adjustments
~0%
~0%
Non-GAAP Gross Margin
24% – 27%
25% – 26%
Q4-24
FY-24
GAAP Operating Expenses
$85 – $86 million
$252 – $254 million
Amortization of acquired intangible assets
~($0) million
~($2) million
Stock-based compensation
~($6) million
~($23) million
Net merger, acquisition and divestiture income (expense)
–
~$75 million
Restructuring and other
~($5) million
~($29) million
Total adjustments
~($11) million
~$22 million
Non-GAAP Operating Expenses
$74 – $75 million
$274 – $276 million
Q4-24
FY-24
GAAP Operating Loss
($43) – ($34) million
($84) – ($75) million
Amortization of acquired intangible assets
~$0 million
~$2 million
Stock-based compensation
~$7 million
~$25 million
Net merger, acquisition and divestiture expense (income)
–
~($75) million
Restructuring and other
~$5 million
~$29 million
Total adjustments
~$12 million
~($20) million
Non-GAAP Operating Loss
($31) – ($22) million
($104) – ($95) million
Q4-24
FY-24
GAAP Net Loss Per Share
($1.88) – ($1.58)
($4.27) – ($3.96)
Amortization of acquired intangible assets
~$0.01
~$0.05
Stock-based compensation
~$0.22
~$0.83
Net merger, acquisition and divestiture expense (income)
–
~($2.53)
Restructuring and other
~$0.15
~$0.98
Loss on strategic investments
–
~$0.01
Debt issuance costs
–
~$0.02
Income tax effect
~$0
~$0
Total adjustments
~$0.38
~($0.64)
Non-GAAP Net Loss Per Share
($1.50) – ($1.20)
($4.91) – ($4.60)
Number of shares used in per share calculations*
~30.6 million
~29.6 million
* Number of shares does not include any additional issuances under our ATM
Certain numbers may not total due to rounding
View original content to download multimedia:https://www.prnewswire.com/news-releases/irobot-reports-third-quarter-2024-financial-results-302297065.html
SOURCE iRobot Corporation
You may like
Technology
Wistron Celebrates Grand Opening of First U.S. Smart Factory Marking Milestone in Global Smart Manufacturing Strategy
Published
59 minutes agoon
July 22, 2026By
FORT WORTH, Texas, July 21, 2026 /PRNewswire/ — Wistron Corporation (“Wistron”) celebrated the grand opening of its D1 AI smart facility in Fort Worth, Texas, the site where the first NVIDIA GB300 Grace Blackwell Ultra Superchip was built and mass-produced in the United States. The US$ 700 million facility, spanning approximately 324,000 square foot, was officially unveiled during a ceremony led by Wistron Chairman Simon Lin and NVIDIA Founder and CEO Jensen Huang. Jessica Rogers, Director of the Economic Development Department for the City of Fort Worth, and Alexander Tah-ray Yui, Taiwan’s Representative to the United States, were among the government officials and business leaders who attended, marking a milestone in the expansion of Wistron’s global footprint and advanced manufacturing capabilities.
This is a key hub in Wistron’s global AI infrastructure manufacturing network. The facility runs on NVIDIA accelerated computing and integrates NVIDIA’s Nemotron and Cosmos open frontier models and Omniverse and Metropolis libraries, using digital twin technology to optimize factory design, production workflows, and operational efficiency. It is Wistron’s first U.S.-based manufacturing facility, established to serve customers locally and produce NVIDIA’s most advanced and cutting-edge products. Wistron Chairman Simon Lin said “The operation here is not typical manufacturing. It is new, very comprehensive, and high-tech. Right now we produce the NVIDIA GB300 Grace Blackwell Ultra Superchip, and beyond, we are also going to produce the NVIDIA Vera Rubin Superchip here. In the next couple of years, this location will be one of the most important, as we build AI infrastructure here in the United States. I think this is the reason we say that there will be the next chapter, and we are going to empower AI from Texas.”
Responding to Customer Needs: Texas, the Newest Global Manufacturing Hub
At this pivotal moment for global AI infrastructure, Wistron is drawing on decades of global manufacturing experience to expand its footprint in Texas, a state with a well-established ecosystem for logistics, talent recruitment, and advanced manufacturing. The new D1 facility produces the NVIDIA GB300 Grace Blackwell Ultra Superchip and soon, the NVIDIA Vera Rubin Superchip — critical to powering the next generation of AI computing. The new Fort Worth facility strengthens a critical upstream layer of the AI infrastructure supply chain by expanding domestic capacity to assemble and test NVIDIA AI systems. These servers can be integrated into NVIDIA DSX infrastructure, with DSX providing the common architecture and technologies needed to deploy and operate energy-efficient AI factories at scale.
One-Stop Operational Ecosystem Strengthens U.S. AI Supply Chain Resilience
Behind every breakthrough in AI computing lies the manufacturing capability to scale it. Wistron is expanding its AI server production capabilities from Taiwan to the United States, guided by a vision of precision, efficiency, and sustainability. This reflects a broader industry shift: AI leadership is determined not only by technological breakthroughs, but also by the operational capability to transform innovation into high-volume production with consistent quality, supply chain resilience, and predictable delivery. By establishing AI infrastructure manufacturing capacity in the United States, Wistron is building a one-stop operational ecosystem spanning manufacturing and after-sales service — shortening delivery timelines and customer support cycles, strengthening supply chain resilience, and laying the foundation for long-term competitive advantage as AI infrastructure continues to scale.
Partnering with NVIDIA to Pioneer a New Model for Smart Manufacturing and Energy Optimization
As the era of physical AI begins, Wistron is extending its smart manufacturing capabilities to the United States, creating a new model for AI infrastructure production built on digital manufacturing, energy optimization, and local operations. Jensen Huang said: “The largest infrastructure buildout in history is underway. Demand for AI factories—the engine of this next industrial revolution—is incredible, and they must be produced everywhere. Together, NVIDIA and Wistron are restoring US advanced manufacturing capacity in Texas, creating skilled jobs and strengthening America’s AI supply chain.” As demand for advanced manufacturing grows in Texas, smarter planning of production loads and energy use will give the plant greater control and flexibility over its electricity needs.
Turning Global Experience into Scalable AI Infrastructure
Simon Lin stressed that the speed the AI era demands comes with its own responsibility. “In the AI era, the pressure of speed is also a form of responsibility,” Lin said. “We don’t just need to build fast; we need to build right.”
The Fort Worth plant will serve as the core engine of Wistron’s U.S. manufacturing operations, the company said, connecting its global production network with ecosystem partners as it scales advanced AI manufacturing. Wistron said that the investment reflects efforts to deepen its technical capabilities, strengthen the resilience and efficiency of global supply chains, and support the next phase of AI infrastructure development.
About Wistron:
Wistron Corporation is a leading global technology service provider delivering advanced ICT products, AI infrastructure, and manufacturing solutions to technology brands worldwide. With more than 63,000 employees across North America, Europe, and Asia, Wistron continues to expand its AI, cloud, and advanced manufacturing capabilities to support the next generation of intelligent computing. For more information about Wistron, please visit the official website at www.wistron.com. Additional information about the event is available on the event website.
Media Contact:
Joyce WL Chou
joyce_wl_chou@wistron.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/wistron-celebrates-grand-opening-of-first-us-smart-factory-marking-milestone-in-global-smart-manufacturing-strategy-302831439.html
SOURCE Wistron Corporation
Technology
NSG Bio Accelerates Breakthrough Biotech Innovation in Singapore
Published
59 minutes agoon
July 22, 2026By
New initiative under NSG Bio Tomorrow will support promising startups developing next-generation approaches in respiratory and neonatal care
SINGAPORE, July 22, 2026 /PRNewswire/ — The NSG Bio Tomorrow initiative aims at supporting emerging life sciences startups working on complex challenges in respiratory and neonatal care.
Launched through the support of Chiesi Group, The Impulse initiative will provide a selected startup with one year of NSG Bio membership and access to a dedicated laboratory bench at NSG Bio Singapore. The initiative is designed to help early-stage biotech companies move from promising science toward stronger proof-of-concept work in a fully equipped research environment.
The initiative comes at a time when the biotech industry is increasingly looking for faster, more connected ways to move high-potential science from the lab toward real-world patient impact. For startups, access to infrastructure is only one part of the challenge. Equally important are the right networks, industry visibility, technical environment, and opportunities to engage with partners who understand the path from early discovery to clinical relevance.
The programme will focus on startups developing innovative biotechnological solutions with potential relevance to chronic respiratory diseases and neonatal conditions. Areas of interest include cell therapies, gene therapies, gene-editing technologies, regenerative tissue engineering, engineered or programmable living systems, lung-targeted delivery platforms, preventive approaches, and small-molecule-based approaches.
The selected startup will gain access to NSG Bio’s laboratory infrastructure, shared workspaces, meeting facilities, and wider community of biotech entrepreneurs, researchers, scientific leaders, and industry partners. The support is intended to help the company advance key research milestones while becoming part of Singapore’s growing life-science innovation ecosystem.
For NSG Bio, the initiative is part of NSG Bio Tomorrow, its ecosystem-building arm created to expand the company’s role beyond facilities and real estate. While NSG Bio is known for providing high-quality laboratory and office infrastructure for biotech companies, NSG Bio Tomorrow focuses on building the programmes, partnerships, and opportunities that help startups grow.
“Biotech companies need more than lab space. They need access, momentum, and the right ecosystem around them,” said Hasyim Sim, Co-Founder and Chief Operating Officer, NSG Bio. “Through NSG Bio Tomorrow, we are building initiatives that help promising startups connect with partners, unlock opportunities, and move their science forward. This initiative reflects exactly the kind of role we want to play in the biotech ecosystem.”
“Chiesi is committed to supporting innovation that can make a meaningful difference for patients, and we work with entrepreneurs, researchers and partners to advance meaningful ideas,” said Fabrizio Conicella, Vice President, Center of Open Innovation & Competence at Chiesi Group. “By supporting this NSG Bio Tomorrow initiative, we want to create an opportunity for early-stage innovators to access the infrastructure and ecosystem support needed to develop impactful science in respiratory and neonatal care.”
NSG Bio Tomorrow programme also reinforces Singapore’s position as a growing hub for biotech innovation in Asia, where startups, research institutions, investors, and industry partners are increasingly coming together to support the next generation of healthcare companies.
Applications open on 22 July 2026 at 09:00 a.m. SGT. Finalists will be invited to present at a virtual pitch event, after which the selected startup will be announced.
About NSG Bio
NSG Bio is Singapore’s leading provider of BSL-2 certified co-working laboratory and office spaces, supporting life-science companies from early research through growth. Through its facilities, community, and ecosystem initiatives, NSG Bio enables biotech innovators to accelerate research, access networks, and build companies that address critical healthcare challenges.
About NSG Bio Tomorrow
NSG Bio Tomorrow is NSG Bio’s ecosystem-building arm, created to support the next generation of biotech innovation through partnerships, programmes, community initiatives, and opportunities that extend beyond physical laboratory infrastructure. Its mission is to strengthen the biotech industry by connecting startups with the resources, expertise, and networks they need to thrive.
About Chiesi Group
Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet high standards of social and environmental impact.
With 90 years of experience, Chiesi is headquartered in Parma (Italy), with 31 affiliates worldwide, and counts more than 7,900 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden. For further information please visit https://www.chiesi.com/en/home
Media Contact
Giridharan
Laboratory Manager
NSG Bio
giridharan@nsgbio.com
87797175
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/nsg-bio-accelerates-breakthrough-biotech-innovation-in-singapore-302830494.html
SOURCE NSG Bio
Technology
House Judiciary Committee Passes Bill that Would Prevent Future Immigration Crises: Swift Action Needed by Full House, Says FAIR
Published
59 minutes agoon
July 22, 2026By
WASHINGTON, July 21, 2026 /PRNewswire/ — Today, the House Judiciary Committee passed an updated version of H.R. 2, the landmark border security bill from last congressional session. The bill now awaits consideration by the full House of Representatives. The Federation for American Immigration Reform (FAIR) urges Speaker Mike Johnson to schedule a final floor vote as soon as possible.
The Secure Border Act systematically closes the loopholes that allowed the Biden administration to unleash the largest and most damaging wave of illegal immigration in American history. Enactment of this legislation would prevent future anti-borders administrations from shirking their responsibilities to secure our borders and enforce our immigration laws; asserting unlimited discretion to parole inadmissible aliens to enter the country; or releasing millions of illegal aliens into the country, rather than detaining them or returning them to the country from which they entered.
“We congratulate the Judiciary Committee for its swift action on this critical legislation,” said Dale Wilcox, executive director and general counsel of FAIR. “Ending border chaos and rampant illegal immigration was a key reason that Republicans regained control of the White House and both chambers of Congress in the last election. The clock is ticking on the 119th Congress, and Republicans only have a short time to deliver on the promises they made to voters in 2024, before the midterms.
“Right now, our immigration laws are being enforced in the interests of the American people. As the last administration demonstrated, enforcement of those laws is not guaranteed unless Congress acts to prevent similar abuse in the future. Now is the time for decisive action in the House, where this bill can be passed with a simple majority vote, and an opportunity for Senate Majority Leader John Thune to put every member of that body on record before voters go to the polls in the fall,” Wilcox concluded.
Hayley Hill, hhill@fairus.org 202-328-7004
View original content to download multimedia:https://www.prnewswire.com/news-releases/house-judiciary-committee-passes-bill-that-would-prevent-future-immigration-crises-swift-action-needed-by-full-house-says-fair-302831443.html
SOURCE Federation for American Immigration Reform (FAIR)
Wistron Celebrates Grand Opening of First U.S. Smart Factory Marking Milestone in Global Smart Manufacturing Strategy
NSG Bio Accelerates Breakthrough Biotech Innovation in Singapore
House Judiciary Committee Passes Bill that Would Prevent Future Immigration Crises: Swift Action Needed by Full House, Says FAIR
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market4 days agoThe British Virgin Islands are a top crypto hub no one ever talks about: Here’s why
-
Technology4 days agoGlobal Times: China sends fresh signal on global AI cooperation at WAIC
-
Technology5 days agoDriving the Agentic AI Era: MiTAC Computing Showcases Comprehensive AI Infrastructure at WAIC
-
Technology4 days agoe& Successfully Completes Sale of Vodafone Stake, Realizing Cash Proceeds of USD 5.95 Billion
-
Technology4 days agoVizEx launches multilingual platform connecting immigrants with licensed U.S. immigration attorneys
-
Technology4 days agoS&P DOW JONES INDICES AND MSCI ANNOUNCE CONSULTATION ON POTENTIAL CHANGES TO THE GLOBAL INDUSTRY CLASSIFICATION STANDARD (GICS®)
-
Technology4 days agoSpryPoint Names Payments Industry Veteran Kevin Gallagher Vice President of Payments
-
Technology5 days agoCake Digital Bank named Vietnam’s Best Digital Bank by Euromoney
